{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:32:37Z","timestamp":1780551157392,"version":"3.54.1"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12035-011-8168-2","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T12:18:07Z","timestamp":1298981887000},"page":"142-159","source":"Crossref","is-referenced-by-count":125,"title":["Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat!"],"prefix":"10.1007","volume":"44","author":[{"given":"Ramaswamy","family":"Kannappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash Chandra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat Bhushan","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"8168_CR1","unstructured":"Anonymus (2010) The market outlook for neurodegenerative diseases: epidemiology, market size, current treatments and future innovation. [Report] Available from: http:\/\/store.business-insights.com\/Product\/the_market_outlook_for_neurodegenerative_diseases?productid=BI00022-077"},{"key":"8168_CR2","unstructured":"Mark C (2010) Neurodegenerative diseases: next-generation drugs for four major disorders. [Report] Available from: http:\/\/www.insightpharmareports.com\/reports_report.aspx?id=86304&r=668"},{"key":"8168_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tips.2005.08.007","volume":"26","author":"B Marchetti","year":"2005","unstructured":"Marchetti B, Abbracchio MP (2005) To be or not to be (inflamed)\u2014is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci 26:517\u2013525","journal-title":"Trends Pharmacol Sci"},{"key":"8168_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S et al (2010) Inflammation in neurodegenerative diseases. Immunology 129:154\u2013169","journal-title":"Immunology"},{"key":"8168_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1874609810801010030","volume":"1","author":"D Galimberti","year":"2008","unstructured":"Galimberti D et al (2008) Inflammation in neurodegenerative disorders: friend or foe? Curr Aging Sci 1:30\u201341","journal-title":"Curr Aging Sci"},{"key":"8168_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/9789812837912_0001","volume-title":"Molecular targets and therapeutic uses of spices","author":"AB Kunnumakkara","year":"2009","unstructured":"Kunnumakkara AB et al (2009) Traditional uses of spices: an overview. In: Aggarwal BB, Kunnumakkara AB (eds) Molecular targets and therapeutic uses of spices. World Scientific, New Jersey, pp 1\u201324"},{"key":"8168_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3181\/0902-MR-78","volume":"234","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB et al (2009) Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp Biol Med Maywood 234:825\u2013849","journal-title":"Exp Biol Med Maywood"},{"key":"8168_CR8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1055\/s-2008-1074578","volume":"74","author":"BB Aggarwal","year":"2008","unstructured":"Aggarwal BB et al (2008) Potential of spice-derived phytochemicals for cancer prevention. Planta Med 74:1560\u20131569","journal-title":"Planta Med"},{"key":"8168_CR9","doi-asserted-by":"crossref","unstructured":"Gupta SC et al. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29:405\u2013434","DOI":"10.1007\/s10555-010-9235-2"},{"key":"8168_CR10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"K Ono","year":"2004","unstructured":"Ono K et al (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro. J Neurosci Res 75:742\u2013750","journal-title":"J Neurosci Res"},{"key":"8168_CR11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-T","volume":"54","author":"P Kuner","year":"1998","unstructured":"Kuner P et al (1998) Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J Neurosci Res 54:798\u2013804","journal-title":"J Neurosci Res"},{"key":"8168_CR12","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.4049\/jimmunol.170.10.5281","volume":"170","author":"RK Giri","year":"2003","unstructured":"Giri RK et al (2003) Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 170:5281\u20135294","journal-title":"J Immunol"},{"key":"8168_CR13","first-page":"161","volume":"12","author":"A Defossez","year":"1986","unstructured":"Defossez A et al (1986) Immunohistochemical study of the basic lesions of Alzheimer\u2019s disease. Encephale 12:161\u2013168","journal-title":"Encephale"},{"key":"8168_CR14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nprot.2006.277","volume":"1","author":"DM Wilcock","year":"2006","unstructured":"Wilcock DM et al (2006) Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc 1:1591\u20131595","journal-title":"Nat Protoc"},{"key":"8168_CR15","first-page":"29","volume":"79","author":"MK Thakur","year":"2000","unstructured":"Thakur MK (2000) Alzheimer\u2019s disease\u2014a challenge in the new millennium. Curr Sci 79:29\u201336","journal-title":"Curr Sci"},{"key":"8168_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.1993.00540040011008","volume":"50","author":"L Berg","year":"1993","unstructured":"Berg L et al (1993) Neuropathological indexes of Alzheimer\u2019s disease in demented and nondemented persons aged 80\u00a0years and older. Arch Neurol 50:349\u2013358","journal-title":"Arch Neurol"},{"key":"8168_CR17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/382674a0","volume":"382","author":"MP Mattson","year":"1996","unstructured":"Mattson MP, Rydel RE (1996) Alzheimer\u2019s disease. Amyloid ox-tox transducers. Nature 382:674\u2013675","journal-title":"Nature"},{"key":"8168_CR18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-4159.2004.02800.x","volume":"91","author":"RK Giri","year":"2004","unstructured":"Giri RK et al (2004) Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91:1199\u20131210","journal-title":"J Neurochem"},{"key":"8168_CR19","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F et al (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892\u20135901","journal-title":"J Biol Chem"},{"key":"8168_CR20","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1021\/jm0607193","volume":"49","author":"EK Ryu","year":"2006","unstructured":"Ryu EK et al (2006) Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J Med Chem 49:6111\u20136119","journal-title":"J Med Chem"},{"key":"8168_CR21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1021\/np010039x","volume":"65","author":"SY Park","year":"2002","unstructured":"Park SY, Kim DS (2002) Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer\u2019s disease. J Nat Prod 65:1227\u20131231","journal-title":"J Nat Prod"},{"key":"8168_CR22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","volume":"22","author":"SA Frautschy","year":"2001","unstructured":"Frautschy SA et al (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22:993\u20131005","journal-title":"Neurobiol Aging"},{"key":"8168_CR23","doi-asserted-by":"crossref","unstructured":"Chonpathompikunlert P et al. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer\u2019s disease. Food Chem Toxicol 48:798\u2013802","DOI":"10.1016\/j.fct.2009.12.009"},{"key":"8168_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jep.2006.05.030","volume":"108","author":"NB Chauhan","year":"2006","unstructured":"Chauhan NB (2006) Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer\u2019s transgenic model Tg2576. J Ethnopharmacol 108:385\u2013394","journal-title":"J Ethnopharmacol"},{"key":"8168_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ptr.2574","volume":"23","author":"VB Gupta","year":"2009","unstructured":"Gupta VB et al (2009) Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: relevance to Alzheimer\u2019s disease. Phytother Res 23:111\u2013115","journal-title":"Phytother Res"},{"key":"8168_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2007.09.042","volume":"429","author":"VB Gupta","year":"2007","unstructured":"Gupta VB, Rao KS (2007) Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer\u2019s beta-amyloid fibrils in vitro. Neurosci Lett 429:75\u201380","journal-title":"Neurosci Lett"},{"key":"8168_CR27","first-page":"BR328","volume":"8","author":"Q Peng","year":"2002","unstructured":"Peng Q et al (2002) Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. Med Sci Monit 8:BR328\u2013BR337","journal-title":"Med Sci Monit"},{"key":"8168_CR28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1124\/jpet.105.099317","volume":"317","author":"T Iuvone","year":"2006","unstructured":"Iuvone T et al (2006) The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 317:1143\u20131149","journal-title":"J Pharmacol Exp Ther"},{"key":"8168_CR29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.phymed.2008.02.022","volume":"15","author":"SH Huang","year":"2008","unstructured":"Huang SH et al (2008) Protective effects of Angelica sinensis extract on amyloid beta-peptide-induced neurotoxicity. Phytomedicine 15:710\u2013721","journal-title":"Phytomedicine"},{"key":"8168_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0278-5846(03)00168-4","volume":"28","author":"JJ Yan","year":"2004","unstructured":"Yan JJ et al (2004) Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry 28:25\u201330","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8168_CR31","doi-asserted-by":"crossref","unstructured":"Lemkul JA, Bevan DR Destabilizing Alzheimer\u2019s Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations. Biochemistry 49:3935\u20133946","DOI":"10.1021\/bi1000855"},{"key":"8168_CR32","doi-asserted-by":"crossref","unstructured":"Guo JP et al Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer\u2019s disease therapy. J Alzheimers Dis 19:1359\u20131370","DOI":"10.3233\/JAD-2010-1331"},{"key":"8168_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1016-8478(23)17016-6","volume":"11","author":"YK Chung","year":"2001","unstructured":"Chung YK et al (2001) Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase. Mol Cells 11:137\u2013143","journal-title":"Mol Cells"},{"key":"8168_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ptr.2063","volume":"21","author":"M Jukic","year":"2007","unstructured":"Jukic M et al (2007) In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res 21:259\u2013261","journal-title":"Phytother Res"},{"key":"8168_CR35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM (1998) Parkinson\u2019s disease. Second of two parts. N Engl J Med 339:1130\u20131143","journal-title":"N Engl J Med"},{"key":"8168_CR36","unstructured":"Jomova K et al. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem"},{"issue":"Suppl 3","key":"8168_CR37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/ana.10566","volume":"53","author":"CW Olanow","year":"2003","unstructured":"Olanow CW et al (2003) Neuroprotection for Parkinson\u2019s disease: prospects and promises. Ann Neurol 53(Suppl 3):S1\u2013S2","journal-title":"Ann Neurol"},{"key":"8168_CR38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-005-0350-0","volume":"113","author":"B Drukarch","year":"2006","unstructured":"Drukarch B et al (2006) The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. J Neural Transm 113:593\u2013598","journal-title":"J Neural Transm"},{"key":"8168_CR39","first-page":"332","volume":"42","author":"TM Martin","year":"2006","unstructured":"Martin TM et al (2006) The effect of conventional and sustained delivery of thymoquinone and levodopa on SH-SY5Y human neuroblastoma cells. Biomed Sci Instrum 42:332\u2013337","journal-title":"Biomed Sci Instrum"},{"key":"8168_CR40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ptr.2708","volume":"23","author":"K Radad","year":"2009","unstructured":"Radad K et al (2009) Thymoquinone protects dopaminergic neurons against MPP+ and rotenone. Phytother Res 23:696\u2013700","journal-title":"Phytother Res"},{"key":"8168_CR41","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/01.wnr.0000239951.14954.10","volume":"17","author":"SJ Kim","year":"2006","unstructured":"Kim SJ et al (2006) Carnosol, a component of rosemary (Rosmarinus officinalis L.) protects nigral dopaminergic neuronal cells. NeuroReport 17:1729\u20131733","journal-title":"NeuroReport"},{"key":"8168_CR42","unstructured":"Filomeni G et al Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson\u2019s disease. Neurobiol Aging"},{"key":"8168_CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1254\/jphs.09045FP","volume":"110","author":"W Qu","year":"2009","unstructured":"Qu W et al (2009) Kaempferol derivatives prevent oxidative stress-induced cell death in a DJ-1-dependent manner. J Pharmacol Sci 110:191\u2013200","journal-title":"J Pharmacol Sci"},{"key":"8168_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tox.2007.12.017","volume":"245","author":"Q Xu","year":"2008","unstructured":"Xu Q et al (2008) Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson\u2019s disease. Toxicology 245:101\u2013108","journal-title":"Toxicology"},{"key":"8168_CR45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10571-009-9411-5","volume":"29","author":"J Bournival","year":"2009","unstructured":"Bournival J et al (2009) Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 29:1169\u20131180","journal-title":"Cell Mol Neurobiol"},{"key":"8168_CR46","doi-asserted-by":"crossref","unstructured":"Vauzour D et al Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1\/2, Nrf-2 and the upregulation of detoxification enzymes. Mol Nutr Food Res 54:532\u2013542","DOI":"10.1002\/mnfr.200900197"},{"key":"8168_CR47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1471-4159.2009.06394.x","volume":"111","author":"A Tarozzi","year":"2009","unstructured":"Tarozzi A et al (2009) Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem 111:1161\u20131171","journal-title":"J Neurochem"},{"key":"8168_CR48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.106.110866","volume":"321","author":"JM Han","year":"2007","unstructured":"Han JM et al (2007) Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 321:249\u2013256","journal-title":"J Pharmacol Exp Ther"},{"key":"8168_CR49","doi-asserted-by":"crossref","unstructured":"Wang MS et al. Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson\u2019s disease cell model. BMC Neurosci 11:57","DOI":"10.1186\/1471-2202-11-57"},{"key":"8168_CR50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","volume":"115","author":"N Pandey","year":"2008","unstructured":"Pandey N et al (2008) Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 115:479\u2013489","journal-title":"Acta Neuropathol"},{"key":"8168_CR51","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","volume":"67","author":"X Li","year":"2008","unstructured":"Li X et al (2008) c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration. J Neuropathol Exp Neurol 67:933\u2013944","journal-title":"J Neuropathol Exp Neurol"},{"key":"8168_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2003.10.012","volume":"48","author":"W Wang","year":"2004","unstructured":"Wang W et al (2004) SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease. Neurosci Res 48:195\u2013202","journal-title":"Neurosci Res"},{"key":"8168_CR53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2007.09.032","volume":"428","author":"J Pan","year":"2007","unstructured":"Pan J et al (2007) Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDA-induced rat model of Parkinson disease. Neurosci Lett 428:82\u201387","journal-title":"Neurosci Lett"},{"key":"8168_CR54","doi-asserted-by":"crossref","unstructured":"Yu S et al Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 13:55\u201364","DOI":"10.1089\/rej.2009.0908"},{"key":"8168_CR55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bcp.2009.03.031","volume":"78","author":"J Wang","year":"2009","unstructured":"Wang J et al (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 78:178\u2013183","journal-title":"Biochem Pharmacol"},{"key":"8168_CR56","doi-asserted-by":"crossref","unstructured":"Harish G et al Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: implications for Parkinson\u2019s disease. Bioorg Med Chem 18:2631\u20132638","DOI":"10.1016\/j.bmc.2010.02.029"},{"issue":"Suppl 3","key":"8168_CR57","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/S1353-8020(09)70812-0","volume":"15","author":"MF Beal","year":"2009","unstructured":"Beal MF (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl 3):S189\u2013S194","journal-title":"Parkinsonism Relat Disord"},{"key":"8168_CR58","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.2174\/138161208786404191","volume":"14","author":"K Ono","year":"2008","unstructured":"Ono K et al (2008) Alpha-synuclein assembly as a therapeutic target of Parkinson\u2019s disease and related disorders. Curr Pharm Des 14:3247\u20133266","journal-title":"Curr Pharm Des"},{"key":"8168_CR59","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.freeradbiomed.2007.11.011","volume":"44","author":"B Jagatha","year":"2008","unstructured":"Jagatha B et al (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson\u2019s disease explained via in silico studies. Free Radic Biol Med 44:907\u2013917","journal-title":"Free Radic Biol Med"},{"key":"8168_CR60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/ars.2006.1479","volume":"9","author":"RB Mythri","year":"2007","unstructured":"Mythri RB et al (2007) Mitochondrial complex I inhibition in Parkinson\u2019s disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9:399\u2013408","journal-title":"Antioxid Redox Signal"},{"key":"8168_CR61","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-006-6715-5","volume":"11","author":"J Chen","year":"2006","unstructured":"Chen J et al (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11:943\u2013953","journal-title":"Apoptosis"},{"key":"8168_CR62","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","volume":"39","author":"V Zbarsky","year":"2005","unstructured":"Zbarsky V et al (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic Res 39:1119\u20131125","journal-title":"Free Radic Res"},{"key":"8168_CR63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","volume":"16","author":"A Rajeswari","year":"2008","unstructured":"Rajeswari A, Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson\u2019s disease induced by MPTP neurodegeneration in mice. Inflammopharmacol 16:96\u201399","journal-title":"Inflammopharmacol"},{"key":"8168_CR64","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s11064-008-9675-z","volume":"33","author":"S Yang","year":"2008","unstructured":"Yang S et al (2008) Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron\/glia culture. Neurochem Res 33:2044\u20132053","journal-title":"Neurochem Res"},{"key":"8168_CR65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A et al (2008) Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol 75:787\u2013809","journal-title":"Biochem Pharmacol"},{"key":"8168_CR66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2006.06.025","volume":"545","author":"C Ramassamy","year":"2006","unstructured":"Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545:51\u201364","journal-title":"Eur J Pharmacol"},{"key":"8168_CR67","doi-asserted-by":"crossref","unstructured":"Ortiz-Ortiz MA et al Curcumin exposure induces expression of the Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci Lett 468:120\u2013124","DOI":"10.1016\/j.neulet.2009.10.081"},{"key":"8168_CR68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11064-005-2606-3","volume":"30","author":"H Kabuto","year":"2005","unstructured":"Kabuto H et al (2005) Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem Res 30:325\u2013332","journal-title":"Neurochem Res"},{"key":"8168_CR69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1248\/bpb.30.423","volume":"30","author":"H Kabuto","year":"2007","unstructured":"Kabuto H et al (2007) Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol Pharm Bull 30:423\u2013427","journal-title":"Biol Pharm Bull"},{"key":"8168_CR70","doi-asserted-by":"crossref","unstructured":"Zhang ZT et al Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo. Acta Pharmacol Sin 31:900\u2013906","DOI":"10.1038\/aps.2010.77"},{"key":"8168_CR71","unstructured":"Bangaru ML et al Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Res 30:499\u2013504"},{"key":"8168_CR72","doi-asserted-by":"crossref","unstructured":"Elamin MH et al Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog 49:302\u2013314","DOI":"10.1002\/mc.20604"},{"key":"8168_CR73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000287236","volume":"91","author":"C Schaaf","year":"2010","unstructured":"Schaaf C et al (2010) Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells. Neuroendocrinology 91:200\u2013210","journal-title":"Neuroendocrinology"},{"key":"8168_CR74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/mol.106.033167","volume":"72","author":"H Aoki","year":"2007","unstructured":"Aoki H et al (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72:29\u201339","journal-title":"Mol Pharmacol"},{"key":"8168_CR75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1471-4159.2007.04633.x","volume":"102","author":"KM Dhandapani","year":"2007","unstructured":"Dhandapani KM et al (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102:522\u2013538","journal-title":"J Neurochem"},{"key":"8168_CR76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-007-9421-4","volume":"85","author":"E Liu","year":"2007","unstructured":"Liu E et al (2007) Curcumin induces G2\/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol 85:263\u2013270","journal-title":"J Neurooncol"},{"key":"8168_CR77","first-page":"39","volume":"5","author":"X Gao","year":"2005","unstructured":"Gao X et al (2005) Curcumin differentially sensitizes malignant glioma cells to TRAIL\/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. J Exp Ther Oncol 5:39\u201348","journal-title":"J Exp Ther Oncol"},{"key":"8168_CR78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbrc.2005.09.079","volume":"337","author":"SY Kim","year":"2005","unstructured":"Kim SY et al (2005) Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337:510\u2013516","journal-title":"Biochem Biophys Res Commun"},{"key":"8168_CR79","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11064-007-9376-z","volume":"32","author":"S Karmakar","year":"2007","unstructured":"Karmakar S et al (2007) Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res 32:2103\u20132113","journal-title":"Neurochem Res"},{"key":"8168_CR80","first-page":"204","volume":"28","author":"AJ Vanisree","year":"2007","unstructured":"Vanisree AJ, Ramanan R (2007) In vitro assessment of curcumin against murine neuroblastoma cells. Neuro Endocrinol Lett 28:204\u2013212","journal-title":"Neuro Endocrinol Lett"},{"key":"8168_CR81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2009.04.149","volume":"384","author":"PM Luthra","year":"2009","unstructured":"Luthra PM et al (2009) Demethoxycurcumin induces Bcl-2 mediated G2\/M arrest and apoptosis in human glioma U87 cells. Biochem Biophys Res Commun 384:420\u2013425","journal-title":"Biochem Biophys Res Commun"},{"key":"8168_CR82","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1677\/ERC-09-0129","volume":"16","author":"C Schaaf","year":"2009","unstructured":"Schaaf C et al (2009) Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 16:1339\u20131350","journal-title":"Endocr Relat Cancer"},{"key":"8168_CR83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4161\/cbt.7.4.5534","volume":"7","author":"N Aravindan","year":"2008","unstructured":"Aravindan N et al (2008) Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 7:569\u2013576","journal-title":"Cancer Biol Ther"},{"key":"8168_CR84","first-page":"209","volume":"28","author":"C Freudlsperger","year":"2008","unstructured":"Freudlsperger C et al (2008) Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. Anticancer Res 28:209\u2013214","journal-title":"Anticancer Res"},{"key":"8168_CR85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s002040050680","volume":"73","author":"F Richeux","year":"1999","unstructured":"Richeux F et al (1999) Cytotoxicity and genotoxicity of capsaicin in human neuroblastoma cells SHSY-5Y. Arch Toxicol 73:403\u2013409","journal-title":"Arch Toxicol"},{"key":"8168_CR86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2002-26757","volume":"68","author":"DS Kim","year":"2002","unstructured":"Kim DS, Oppel MN (2002) Shogaols from Zingiber officinale protect IMR32 human neuroblastoma and normal human umbilical vein endothelial cells from beta-amyloid(25\u201335) insult. Planta Med 68:375\u2013376","journal-title":"Planta Med"},{"key":"8168_CR87","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mc.20490","volume":"48","author":"HC Huang","year":"2009","unstructured":"Huang HC et al (2009) Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP\/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog 48:517\u2013531","journal-title":"Mol Carcinog"},{"key":"8168_CR88","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1158\/1078-0432.CCR-04-1827","volume":"11","author":"NM Tsai","year":"2005","unstructured":"Tsai NM et al (2005) The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin Cancer Res 11:3475\u20133484","journal-title":"Clin Cancer Res"},{"key":"8168_CR89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000095560","volume":"73","author":"WH Lee","year":"2006","unstructured":"Lee WH et al (2006) Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma. Pathobiology 73:141\u2013148","journal-title":"Pathobiology"},{"key":"8168_CR90","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2006.04151.x","volume":"99","author":"NM Tsai","year":"2006","unstructured":"Tsai NM et al (2006) The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J Neurochem 99:1251\u20131262","journal-title":"J Neurochem"},{"key":"8168_CR91","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1471-4159.2008.05432.x","volume":"106","author":"PC Lin","year":"2008","unstructured":"Lin PC et al (2008) Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor. J Neurochem 106:1017\u20131026","journal-title":"J Neurochem"},{"key":"8168_CR92","doi-asserted-by":"crossref","first-page":"16329","DOI":"10.1073\/pnas.0706662104","volume":"104","author":"SW Jang","year":"2007","unstructured":"Jang SW et al (2007) Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc Natl Acad Sci USA 104:16329\u201316334","journal-title":"Proc Natl Acad Sci USA"},{"key":"8168_CR93","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bcp.2007.10.033","volume":"75","author":"L Qiang","year":"2008","unstructured":"Qiang L et al (2008) Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem Pharmacol 75:1083\u20131092","journal-title":"Biochem Pharmacol"},{"key":"8168_CR94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.11.026","volume":"184","author":"O Aktas","year":"2007","unstructured":"Aktas O et al (2007) Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets. J Neuroimmunol 184:17\u201326","journal-title":"J Neuroimmunol"},{"key":"8168_CR95","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2009.01.025","volume":"9","author":"L Xie","year":"2009","unstructured":"Xie L et al (2009) Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 9:575\u2013581","journal-title":"Int Immunopharmacol"},{"key":"8168_CR96","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10875-008-9202-7","volume":"28","author":"W Chearwae","year":"2008","unstructured":"Chearwae W, Bright JJ (2008) 15-deoxy-Delta(12, 14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. J Clin Immunol 28:558\u2013570","journal-title":"J Clin Immunol"},{"key":"8168_CR97","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1582-4934.2007.00089.x","volume":"11","author":"AJ Fahey","year":"2007","unstructured":"Fahey AJ et al (2007) Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J Cell Mol Med 11:1129\u20131137","journal-title":"J Cell Mol Med"},{"key":"8168_CR98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-6-29","volume":"6","author":"TC Theoharides","year":"2009","unstructured":"Theoharides TC (2009) Luteolin as a therapeutic option for multiple sclerosis. J Neuroinflammation 6:29","journal-title":"J Neuroinflammation"},{"key":"8168_CR99","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-6-28","volume":"6","author":"Z Sternberg","year":"2009","unstructured":"Sternberg Z et al (2009) Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta. J Neuroinflammation 6:28","journal-title":"J Neuroinflammation"},{"key":"8168_CR100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.09.008","volume":"205","author":"Z Sternberg","year":"2008","unstructured":"Sternberg Z et al (2008) Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. J Neuroimmunol 205:142\u2013147","journal-title":"J Neuroimmunol"},{"key":"8168_CR101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jep.2004.05.021","volume":"94","author":"M Sayyah","year":"2004","unstructured":"Sayyah M et al (2004) Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J Ethnopharmacol 94:283\u2013287","journal-title":"J Ethnopharmacol"},{"key":"8168_CR102","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.neuroscience.2008.07.024","volume":"156","author":"J Song","year":"2008","unstructured":"Song J et al (2008) DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy. Neuroscience 156:722\u2013728","journal-title":"Neuroscience"},{"key":"8168_CR103","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/ptr.2816","volume":"23","author":"AK Jager","year":"2009","unstructured":"Jager AK et al (2009) Bioassay-guided isolation of apigenin with GABA-benzodiazepine activity from Tanacetum parthenium. Phytother Res 23:1642\u20131644","journal-title":"Phytother Res"},{"key":"8168_CR104","first-page":"27","volume":"18","author":"B Dib","year":"1996","unstructured":"Dib B, Falchi M (1996) Convulsions and death induced in rats by Tween 80 are prevented by capsaicin. Int J Tissue React 18:27\u201331","journal-title":"Int J Tissue React"},{"key":"8168_CR105","unstructured":"Mehla J et al Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci"},{"key":"8168_CR106","doi-asserted-by":"crossref","unstructured":"Kulkarni SK, Dhir A An overview of curcumin in neurological disorders. Indian J Pharm Sci 72:149\u2013154","DOI":"10.4103\/0250-474X.65012"},{"key":"8168_CR107","first-page":"39","volume":"53","author":"YK Gupta","year":"2009","unstructured":"Gupta YK et al (2009) Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J Physiol Pharmacol 53:39\u201346","journal-title":"Indian J Physiol Pharmacol"},{"key":"8168_CR108","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroscience.2006.02.036","volume":"140","author":"M Muller","year":"2006","unstructured":"Muller M et al (2006) Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues. Neuroscience 140:743\u2013751","journal-title":"Neuroscience"},{"key":"8168_CR109","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1211\/jpp.61.07.0013","volume":"61","author":"AC Neto","year":"2009","unstructured":"Neto AC et al (2009) The role of polar phytocomplexes on anticonvulsant effects of leaf extracts of Lippia alba (Mill.) N.E. Brown chemotypes. J Pharm Pharmacol 61:933\u2013939","journal-title":"J Pharm Pharmacol"},{"key":"8168_CR110","first-page":"557","volume":"46","author":"R D\u2019Hooge","year":"1996","unstructured":"D\u2019Hooge R et al (1996) Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung 46:557\u2013560","journal-title":"Arzneimittelforschung"},{"key":"8168_CR111","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/jmf.2005.8.392","volume":"8","author":"D Joshi","year":"2005","unstructured":"Joshi D et al (2005) Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J Med Food 8:392\u2013396","journal-title":"J Med Food"},{"key":"8168_CR112","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1523\/JNEUROSCI.3944-06.2007","volume":"27","author":"J Song","year":"2007","unstructured":"Song J et al (2007) Seizure suppression by top1 mutations in Drosophila. J Neurosci 27:2927\u20132937","journal-title":"J Neurosci"},{"key":"8168_CR113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2009.01.007","volume":"85","author":"DJ Ellens","year":"2009","unstructured":"Ellens DJ et al (2009) Development of spike-wave seizures in C3H\/HeJ mice. Epilepsy Res 85:53\u201359","journal-title":"Epilepsy Res"},{"key":"8168_CR114","unstructured":"Who (2006) Depression. Available from: www.who.int\/mental_health\/management\/depression\/definition\/en\/print.html"},{"key":"8168_CR115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0327(00)00153-1","volume":"60","author":"A Coppen","year":"2000","unstructured":"Coppen A, Bailey J (2000) Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 60:121\u2013130","journal-title":"J Affect Disord"},{"key":"8168_CR116","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1497.1999.03478.x","volume":"14","author":"LS Goldman","year":"1999","unstructured":"Goldman LS et al (1999) Awareness, diagnosis, and treatment of depression. J Gen Intern Med 14:569\u2013580","journal-title":"J Gen Intern Med"},{"key":"8168_CR117","unstructured":"NCCAM (2004) What is complementary and alternative medicine? Available from: http:\/\/nccam.nih.gov\/health\/whatiscam\/"},{"key":"8168_CR118","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","volume":"201","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK et al (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacol Berl 201:435\u2013442","journal-title":"Psychopharmacol Berl"},{"key":"8168_CR119","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1100\/tsw.2009.137","volume":"9","author":"S Kulkarni","year":"2009","unstructured":"Kulkarni S et al (2009) Potentials of curcumin as an antidepressant. ScientificWorldJournal 9:1233\u20131241","journal-title":"ScientificWorldJournal"},{"key":"8168_CR120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pbb.2005.08.009","volume":"82","author":"Y Xu","year":"2005","unstructured":"Xu Y et al (2005) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200\u2013206","journal-title":"Pharmacol Biochem Behav"},{"key":"8168_CR121","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1248\/bpb.26.474","volume":"26","author":"T Nakazawa","year":"2003","unstructured":"Nakazawa T et al (2003) Antidepressant-like effects of apigenin and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol Pharm Bull 26:474\u2013480","journal-title":"Biol Pharm Bull"},{"key":"8168_CR122","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainres.2004.03.040","volume":"1011","author":"Y Irie","year":"2004","unstructured":"Irie Y et al (2004) Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 1011:243\u2013246","journal-title":"Brain Res"},{"key":"8168_CR123","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.lfs.2006.12.027","volume":"80","author":"S Li","year":"2007","unstructured":"Li S et al (2007) Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sci 80:1373\u20131381","journal-title":"Life Sci"},{"key":"8168_CR124","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","volume":"79","author":"P Lipton","year":"1999","unstructured":"Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431\u20131568","journal-title":"Physiol Rev"},{"key":"8168_CR125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2006.12.028","volume":"561","author":"J Jiang","year":"2007","unstructured":"Jiang J et al (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 561:54\u201362","journal-title":"Eur J Pharmacol"},{"key":"8168_CR126","doi-asserted-by":"crossref","unstructured":"Zhao J et al Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 35:374\u2013379","DOI":"10.1007\/s11064-009-0065-y"},{"key":"8168_CR127","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s11064-007-9515-6","volume":"33","author":"P Rathore","year":"2008","unstructured":"Rathore P et al (2008) Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem Res 33:1672\u20131682","journal-title":"Neurochem Res"},{"key":"8168_CR128","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s11064-007-9547-y","volume":"33","author":"PK Shukla","year":"2008","unstructured":"Shukla PK et al (2008) Anti-ischemic effect of curcumin in rat brain. Neurochem Res 33:1036\u20131043","journal-title":"Neurochem Res"},{"key":"8168_CR129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.lfs.2003.06.042","volume":"74","author":"M Thiyagarajan","year":"2004","unstructured":"Thiyagarajan M, Sharma SS (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969\u2013985","journal-title":"Life Sci"},{"key":"8168_CR130","first-page":"1314","volume":"32","author":"CY Li","year":"2007","unstructured":"Li CY, Cheng XS (2007) Effects of allicin on changes of hemorheology in focal cerebral ischemia-reperfusion injury. Zhongguo Zhong Yao Za Zhi 32:1314\u20131317","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"8168_CR131","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neuint.2007.10.005","volume":"52","author":"SK Ha","year":"2008","unstructured":"Ha SK et al (2008) Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int 52:878\u2013886","journal-title":"Neurochem Int"},{"key":"8168_CR132","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brainres.2007.08.087","volume":"1182","author":"C Lopez-Sanchez","year":"2007","unstructured":"Lopez-Sanchez C et al (2007) Blood micromolar concentrations of kaempferol afford protection against ischemia\/reperfusion-induced damage in rat brain. Brain Res 1182:123\u2013137","journal-title":"Brain Res"},{"key":"8168_CR133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03033562","volume":"13","author":"F Rivera","year":"2008","unstructured":"Rivera F et al (2008) Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox Res 13:105\u2013114","journal-title":"Neurotox Res"},{"key":"8168_CR134","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2005.09.065","volume":"393","author":"J Zhao","year":"2006","unstructured":"Zhao J et al (2006) Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393:108\u2013112","journal-title":"Neurosci Lett"},{"key":"8168_CR135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-9964(03)00011-2","volume":"65","author":"RM Marchbanks","year":"2003","unstructured":"Marchbanks RM et al (2003) A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65:33\u201338","journal-title":"Schizophr Res"},{"key":"8168_CR136","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00702-007-0867-5","volume":"115","author":"M Mizuno","year":"2008","unstructured":"Mizuno M et al (2008) The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia. J Neural Transm 115:521\u2013530","journal-title":"J Neural Transm"},{"key":"8168_CR137","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.77.9.5499-5502.2003","volume":"77","author":"B Caughey","year":"2003","unstructured":"Caughey B et al (2003) Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 77:5499\u20135502","journal-title":"J Virol"},{"key":"8168_CR138","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1471-4159.2007.05105.x","volume":"104","author":"I Hafner-Bratkovic","year":"2008","unstructured":"Hafner-Bratkovic I et al (2008) Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein\u2014a new mechanism for the inhibition of PrP(Sc) accumulation. J Neurochem 104:1553\u20131564","journal-title":"J Neurochem"},{"key":"8168_CR139","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/14656566.8.10.1493","volume":"8","author":"M Weisfelt","year":"2007","unstructured":"Weisfelt M et al (2007) Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin Pharmacother 8:1493\u20131504","journal-title":"Expert Opin Pharmacother"},{"key":"8168_CR140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2006-959568","volume":"60","author":"LE Davis","year":"1994","unstructured":"Davis LE et al (1994) In vitro synergism of concentrated Allium sativum extract and amphotericin B against Cryptococcus neoformans. Planta Med 60:546\u2013549","journal-title":"Planta Med"},{"key":"8168_CR141","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2006-957929","volume":"62","author":"J Shen","year":"1996","unstructured":"Shen J et al (1996) Enhanced diallyl trisulfide has in vitro synergy with amphotericin B against Cryptococcus neoformans. Planta Med 62:415\u2013418","journal-title":"Planta Med"},{"key":"8168_CR142","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3923\/pjbs.2007.2583.2586","volume":"10","author":"H Tajik","year":"2007","unstructured":"Tajik H et al (2007) Interaction between curcumin and opioid system in the formalin test of rats. Pak J Biol Sci 10:2583\u20132586","journal-title":"Pak J Biol Sci"},{"key":"8168_CR143","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3923\/pjbs.2008.312.314","volume":"11","author":"H Tajik","year":"2008","unstructured":"Tajik H et al (2008) The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats. Pak J Biol Sci 11:312\u2013314","journal-title":"Pak J Biol Sci"},{"key":"8168_CR144","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNR.0b013e328314decb","volume":"20","author":"Y Matsushita","year":"2009","unstructured":"Matsushita Y, Ueda H (2009) Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. NeuroReport 20:63\u201368","journal-title":"NeuroReport"},{"key":"8168_CR145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","volume":"28","author":"L Baum","year":"2008","unstructured":"Baum L et al (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28:110\u2013113","journal-title":"J Clin Psychopharmacol"},{"key":"8168_CR146","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-2009-1080","volume":"17","author":"A Masoumi","year":"2009","unstructured":"Masoumi A et al (2009) 1alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis 17:703\u2013717","journal-title":"J Alzheimers Dis"},{"key":"8168_CR147","first-page":"469","volume":"24","author":"SS Ambegaokar","year":"2003","unstructured":"Ambegaokar SS et al (2003) Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuro Endocrinol Lett 24:469\u2013473","journal-title":"Neuro Endocrinol Lett"},{"key":"8168_CR148","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1211\/jpp.60.10.0014","volume":"60","author":"MN Ghayur","year":"2008","unstructured":"Ghayur MN et al (2008) Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 60:1375\u20131383","journal-title":"J Pharm Pharmacol"},{"key":"8168_CR149","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-0-387-72005-0_45","volume":"601","author":"TC Theoharides","year":"2007","unstructured":"Theoharides TC et al (2007) Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. Adv Exp Med Biol 601:423\u2013430","journal-title":"Adv Exp Med Biol"},{"key":"8168_CR150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-8741(93)90026-2","volume":"39","author":"B Abila","year":"1993","unstructured":"Abila B et al (1993) Anticonvulsant effects of extracts of the West African black pepper, Piper guineense. J Ethnopharmacol 39:113\u2013117","journal-title":"J Ethnopharmacol"},{"key":"8168_CR151","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2007.01.044","volume":"562","author":"SA Guenette","year":"2007","unstructured":"Guenette SA et al (2007) Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats. Eur J Pharmacol 562:60\u201367","journal-title":"Eur J Pharmacol"},{"key":"8168_CR152","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2005.12.008","volume":"53","author":"C Zhan","year":"2006","unstructured":"Zhan C, Yang J (2006) Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53:303\u2013309","journal-title":"Pharmacol Res"},{"key":"8168_CR153","first-page":"209","volume":"32","author":"JW Yang","year":"2005","unstructured":"Yang JW et al (2005) The effects of Chinese herb Angelica in focal cerebral ischemia injury in the rat. Clin Hemorheol Microcirc 32:209\u2013215","journal-title":"Clin Hemorheol Microcirc"},{"key":"8168_CR154","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1142\/S0192415X08006570","volume":"36","author":"CY Cheng","year":"2008","unstructured":"Cheng CY et al (2008) Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med 36:1105\u20131119","journal-title":"Am J Chin Med"},{"key":"8168_CR155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jep.2008.03.023","volume":"118","author":"Z Lin","year":"2008","unstructured":"Lin Z et al (2008) Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion. J Ethnopharmacol 118:140\u2013147","journal-title":"J Ethnopharmacol"},{"key":"8168_CR156","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1248\/yakushi.129.855","volume":"129","author":"L Zhang","year":"2009","unstructured":"Zhang L et al (2009) Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats. Yakugaku Zasshi 129:855\u2013859","journal-title":"Yakugaku Zasshi"},{"key":"8168_CR157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1248\/bpb.17.403","volume":"17","author":"S Unchern","year":"1994","unstructured":"Unchern S et al (1994) Piperine, a pungent alkaloid, is cytotoxic to cultured neurons from the embryonic rat brain. Biol Pharm Bull 17:403\u2013406","journal-title":"Biol Pharm Bull"},{"key":"8168_CR158","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12272-009-1914-6","volume":"32","author":"LQ Qiang","year":"2009","unstructured":"Qiang LQ et al (2009) Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats. Arch Pharm Res 32:1281\u20131292","journal-title":"Arch Pharm Res"},{"key":"8168_CR159","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.pnpbp.2009.03.001","volume":"33","author":"LT Yi","year":"2009","unstructured":"Yi LT et al (2009) Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry 33:616\u2013624","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8168_CR160","first-page":"987","volume":"24","author":"A Liontas","year":"2004","unstructured":"Liontas A, Yeger H (2004) Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24:987\u2013998","journal-title":"Anticancer Res"},{"key":"8168_CR161","first-page":"113","volume":"21","author":"YS Lee","year":"2002","unstructured":"Lee YS et al (2002) Redox status-dependent regulation of cyclooxygenases mediates the capsaicin-induced apoptosis in human neuroblastoma cells. J Environ Pathol Toxicol Oncol 21:113\u2013120","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"8168_CR162","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1471-4159.2007.04582.x","volume":"102","author":"C Amantini","year":"2007","unstructured":"Amantini C et al (2007) Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 102:977\u2013990","journal-title":"J Neurochem"},{"key":"8168_CR163","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1002\/pmic.200800094","volume":"8","author":"YM Baek","year":"2008","unstructured":"Baek YM et al (2008) A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics 8:4748\u20134767","journal-title":"Proteomics"},{"key":"8168_CR164","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","volume":"300","author":"ST DeKosky","year":"2008","unstructured":"DeKosky ST et al (2008) Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300:2253\u20132262","journal-title":"JAMA"},{"key":"8168_CR165","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/aje\/kwj267","volume":"164","author":"TP Ng","year":"2006","unstructured":"Ng TP et al (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164:898\u2013906","journal-title":"Am J Epidemiol"},{"key":"8168_CR166","doi-asserted-by":"crossref","unstructured":"Kennedy DO et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 91:1590\u20131597","DOI":"10.3945\/ajcn.2009.28641"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-011-8168-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-011-8168-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-011-8168-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:21:30Z","timestamp":1712247690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-011-8168-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":166,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["8168"],"URL":"https:\/\/doi.org\/10.1007\/s12035-011-8168-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}